Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Beacon Pharmaceuticals Limited, DCC Vital, Westminster Industrial Estate, Repton Road, Measham, DE12 7DT, England
CLASTEON 400mg capsules.
Sodium Clodronate 400mg capsules.
| Pharmaceutical Form |
|---|
|
Hard capsules for oral administration. The capsules are oblong, white and blue, marked “CLASTEON”. |
Each capsule contains 400mg sodium clodronate (as the tetrahydrate).
For excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clodronic acid |
Clodronic acid is a bisphosphonate, (formerly diphosphonates), a group of analogues of pyrophosphate, which have been shown, in vitro, to inhibit the formation and dissolution of calcium phosphate (hydroxyapatite). In vivo, they have been shown to inhibit bone resorption to a greater or lesser extent, depending on the compound, and clodronate is one of the most effective in this respect. |
| List of Excipients |
|---|
|
Capsule content: Maize starch, Talc, Magnesium stearate, Sodium starch glycolate. Capsule shell: Titanium dioxide (E171), Indigotin (E132), Gelatin. |
PVC/PVDC/aluminium Blister Packs containing 30, 60 or 120 capsules.
Beacon Pharmaceuticals Limited, DCC Vital, Westminster Industrial Estate, Repton Road, Measham, DE12 7DT, England
PL 18157/0028
15 May 2007 / 13/09/2011
| Drug | Countries | |
|---|---|---|
| CLASTEON | Canada, Israel, Italy, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
